Literature DB >> 5041458

Effect of -hydroxybutyrate on the release of monoamines from the rat striatum.

G Bustos, R H Roth.   

Abstract

A simple in vitro system was developed to study the effect of gamma-hydroxybutyrate on nerve cell depolarization-induced release of labelled DA and 5-hydroxytryptamine. The release of (3)H-dopamine formed in rat striatal slices incubated with (3)3H-tyrosine was followed. A three minute exposure to K+ (53.0 mM) caused a thirty-fold increase in the release of newly synthesized (3)H-dopamine. This K + -induced release was antagonized when gamma-hydroxybutyrate (1 mM) was present in the medium. Potassium (53.0 mM) increased (eighteen-fold) the release of (3)H-dopamine from striatal slices initially loaded by preincubation with (3)H-dopamine. The K + -induced release of this pool of DA was, however, not antagonized by gamma-hydroxybutyrate.Potassium (53.0 mM) also increased the release from striatal slices of (3)H-5-hydroxytryptamine (5-HT) newly synthesized from (3)H-tryptophan. This K + -induced release of 5-HT was also not inhibited by gamma-hydroxybutyrate. The ability of gamma-hydroxybutyrate to antagonize only the K + -induced release of newly formed DA may explain why this agent causes a rapid and selective increase in brain dopamine.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5041458      PMCID: PMC1665998          DOI: 10.1111/j.1476-5381.1972.tb07322.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  11 in total

1.  Gamma-butyrolactone and gamma-hydroxybutyric acid. II. The pharmacologically active form.

Authors:  R H Roth; J M Delgado; N J Giarman
Journal:  Int J Neuropharmacol       Date:  1966-11

2.  A pharmacologic analysis of Huntington's chorea.

Authors:  H L Klawans
Journal:  Eur Neurol       Date:  1970       Impact factor: 1.710

3.  Stimulation of brain dopamine synthesis by gamma-hydroxybutyrate.

Authors:  P F Spano; A Tagliamonte; P Tagliamonte; G L Gessa
Journal:  J Neurochem       Date:  1971-10       Impact factor: 5.372

4.  Effect of anesthetic doses of hydroxybutyrate on subcortical concentrations of homovanillic acid.

Authors:  R H Roth
Journal:  Eur J Pharmacol       Date:  1971-06       Impact factor: 4.432

5.  The action of reserpine on noradrenaline biosynthesis in sympathetic nerve tissue.

Authors:  R H Roth; E A Stone
Journal:  Biochem Pharmacol       Date:  1968-08       Impact factor: 5.858

6.  Gamma-hydroxybutyrate-induced increase in brain dopamine: localization by fluorescence microscopy.

Authors:  G K Aghajanian; R H Roth
Journal:  J Pharmacol Exp Ther       Date:  1970-10       Impact factor: 4.030

7.  Relationship between pharmacological effects and blood and brain levels of gamma-butyrolactone and gamma-hydroxybutyrate.

Authors:  A Guidotti; P L Ballotti
Journal:  Biochem Pharmacol       Date:  1970-03       Impact factor: 5.858

8.  Mechanism of the gamma-hydroxybutyrate-induced increase in brain dopamine and its relationship to "sleep".

Authors:  R H Roth; Y Suhr
Journal:  Biochem Pharmacol       Date:  1970-12       Impact factor: 5.858

9.  [Effects of the injection of gamma-hydroxybutyrate of Na and of gamma-butyrrolactone into different zones of the brain and into the cerebrospinal fluid system. II. Influence on the cerebral dopamine content in the rabbit].

Authors:  L G Gessa; L Vargiu; F Crabai; G Bezzi; R Camba
Journal:  Boll Soc Ital Biol Sper       Date:  1967-03-31

10.  Some neurochemical aspects of the depressant action of gamma-butyrolactone on the central nervous system.

Authors:  N J GIARMAN; K F SCHMIDT
Journal:  Br J Pharmacol Chemother       Date:  1963-06
View more
  5 in total

Review 1.  gamma-Hydroxybutyrate/sodium oxybate: neurobiology, and impact on sleep and wakefulness.

Authors:  Daniel Pardi; Jed Black
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

2.  Effects of phospholipases, proteases and neuraminidase on gamma-hydroxybutyrate binding sites.

Authors:  V Hechler; M Mersel; H Dreyfus; M Maitre
Journal:  Mol Cell Biochem       Date:  1990-03-05       Impact factor: 3.396

3.  Pharmacological evidence for a selective antidopaminergic action of gamma-hydroxybutyric acid.

Authors:  K Menon; D Bieger; O Hornykiewicz
Journal:  J Neural Transm       Date:  1976       Impact factor: 3.575

4.  Inhibition by gamma-hydroxybutyrate of chlorpromazine-induced increase in homovanillic acid.

Authors:  R H Roth
Journal:  Br J Pharmacol       Date:  1973-02       Impact factor: 8.739

5.  Release of monoamines from the striatum and hypothalamus: effect of -hydroxybutyrate.

Authors:  G Bustos; R H Roth
Journal:  Br J Pharmacol       Date:  1972-09       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.